TTM
$18.10B
YoY change
+16.1%
5Y CAGR
+33.5%
Peak year (2025)
$23.49B
Cumulative operating income
$277.23B
Operating Income history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $23.49B
Operating Income growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: +16.1%
Operating Income history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $23.49B | +16.1% | +$3.27B | ||
| 2024 | $20.22B | +584.5% | +$17.27B | ||
| 2023 | $2.95B | -83.8% | −$15.33B | ||
| 2022 | $18.28B | +38.5% | +$5.08B | ||
| 2021 | $13.20B | +137.9% | +$7.65B | ||
| 2020 | $5.55B | -30.0% | −$2.38B | ||
| 2019 | $7.93B | -11.3% | −$1.00B | ||
| 2018 | $8.93B | +31.4% | +$2.13B | ||
| 2017 | $6.80B | +23.6% | +$1.30B | ||
| 2016 | $5.50B | -27.1% | −$2.05B | ||
| 2015 | $7.55B | +12.9% | +$864.00M | ||
| 2014 | $6.68B | -12.8% | −$982.00M | ||
| 2013 | $7.67B | -22.4% | −$2.21B | ||
| 2012 | $9.88B | +10.0% | +$901.00M | ||
| 2011 | $8.98B | +167.5% | +$5.62B | ||
| 2010 | $3.35B | -16.6% | −$666.00M | ||
| 2009 | $4.02B | -33.9% | −$2.06B | ||
| 2008 | $6.08B | +8.3% | +$467.50M | ||
| 2007 | $5.62B | +52.4% | +$1.93B | ||
| 2006 | $3.69B | -37.1% | −$2.17B | ||
| 2005 | $5.86B | -13.3% | −$899.40M | ||
| 2004 | $6.76B | -21.1% | −$1.81B | ||
| 2003 | $8.57B | -5.7% | −$520.50M | ||
| 2002 | $9.09B | -2.0% | −$188.80M | ||
| 2001 | $9.28B | +2.1% | +$189.00M | ||
| 2000 | $9.09B | +19.7% | +$1.49B | ||
| 1999 | $7.59B | +19.1% | +$1.22B | ||
| 1998 | $6.38B | +8.7% | +$512.30M | ||
| 1997 | $5.86B | +17.6% | +$879.00M | ||
| 1996 | $4.98B | +13.2% | +$581.10M | ||
| 1995 | $4.40B | -0.0% | −$1.50M | ||
| 1994 | $4.41B | +13.4% | +$519.40M | ||
| 1993 | $3.89B | +11.3% | +$394.20M | ||
| 1992 | $3.49B | +12.3% | +$381.80M | ||
| 1991 | $3.11B | +17.3% | +$458.30M | ||
| 1990 | $2.65B | +18.6% | +$415.10M | ||
| 1989 | $2.24B | +19.8% | +$369.50M | ||
| 1988 | $1.87B | +36.3% | +$497.60M | ||
| 1987 | $1.37B | +31.5% | +$328.00M | ||
| 1986 | $1.04B | +24.0% | +$201.40M | ||
| 1985 | $839.80M | — | — |
- 2025$23.49B+16.1%
- 2024$20.22B+584.5%
- 2023$2.95B-83.8%
- 2022$18.28B+38.5%
- 2021$13.20B+137.9%
- 2020$5.55B-30.0%
- 2019$7.93B-11.3%
- 2018$8.93B+31.4%
- 2017$6.80B+23.6%
- 2016$5.50B-27.1%
- 2015$7.55B+12.9%
- 2014$6.68B-12.8%
- 2013$7.67B-22.4%
- 2012$9.88B+10.0%
- 2011$8.98B+167.5%
- 2010$3.35B-16.6%
- 2009$4.02B-33.9%
- 2008$6.08B+8.3%
- 2007$5.62B+52.4%
- 2006$3.69B-37.1%
- 2005$5.86B-13.3%
- 2004$6.76B-21.1%
- 2003$8.57B-5.7%
- 2002$9.09B-2.0%
- 2001$9.28B+2.1%
- 2000$9.09B+19.7%
- 1999$7.59B+19.1%
- 1998$6.38B+8.7%
- 1997$5.86B+17.6%
- 1996$4.98B+13.2%
- 1995$4.40B-0.0%
- 1994$4.41B+13.4%
- 1993$3.89B+11.3%
- 1992$3.49B+12.3%
- 1991$3.11B+17.3%
- 1990$2.65B+18.6%
- 1989$2.24B+19.8%
- 1988$1.87B+36.3%
- 1987$1.37B+31.5%
- 1986$1.04B+24.0%
- 1985$839.80M—
Operating Income values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current operating income (TTM) is $18.10B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Merck & Co. (MRK) operating income totalled $23.49B – grew 16.1% year-over-year.
Merck & Co. operating income has grown for 2 consecutive years, with a +33.5% compound annual growth rate over 2020–2025 (5 years).
$23.49B stands as the all-time-high annual operating income, posted in 2025, against a low of $839.80M during 1985.
Merck & Co. Operating Income by Year
Merck & Co. Operating Income 2025: $23.49B
Merck & Co. operating income in 2025 was $23.49B, grew 16.1% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Operating Income 2024: $20.22B
2024's operating income for Merck & Co. came in at $20.22B, surged 584.5% from 2023.
Merck & Co. Operating Income 2023: $2.95B
Merck & Co. posted operating income of $2.95B in 2023, plunged 83.8% below 2022.
Merck & Co. Operating Income 2022: $18.28B
In 2022, Merck & Co. reported operating income of $18.28B, surged 38.5% from 2021.
Merck & Co. Operating Income 2021: $13.20B
Merck & Co. operating income in 2021 was $13.20B.
See more financial history for Merck & Co. (MRK).
Sector peers by Operating Income
Healthcare peers of Merck & Co. (MRK), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B | |
| $8.11B |
- $29.70B
- $25.60B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation